Management of resistance to EGFR TKI–Targeted therapy of lung cancer: Lessons in monitoring cancer evolution

Arkadiusz Z. Dudek

Research output: Contribution to journalArticlepeer-review

Abstract

Cancer cells undergo accelerated evolutionary changes; thus, under the pressure of novel generations of EGFR TKIs, we should expect to see new mechanisms of resistance.

Original languageEnglish (US)
JournalONCOLOGY (United States)
Volume30
Issue number7
StatePublished - Jul 15 2016

Fingerprint Dive into the research topics of 'Management of resistance to EGFR TKI–Targeted therapy of lung cancer: Lessons in monitoring cancer evolution'. Together they form a unique fingerprint.

Cite this